A large global Pharma company was required to run a complex global safety study by regulatory authorities. This was a crucial study to ensure that patients were not exposed to risk.
Cisiv was able to build a study in 10 weeks and launch it across 21 countries. Cisiv’s platform – Baseline Plus – was able to deal with complex data capture, analysis and reporting to various licensing authorities.
... to learn more, download the full case study
ResourcesPASS case study Cisiv